• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Association between type-specific influenza circulation and incidence of severe laboratory-confirmed cases; which subtype is the most virulent?

tetano

Editor, Senior Moderator
Clin Microbiol Infect. 2019 Nov 21. pii: S1198-743X(19)30617-2. doi: 10.1016/j.cmi.2019.11.018. [Epub ahead of print] [h=1]Association between type-specific influenza circulation and incidence of severe laboratory-confirmed cases; which subtype is the most virulent?[/h]
Lytras T[SUP]1[/SUP], Andreopoulou A[SUP]2[/SUP], Gkolfinopoulou K[SUP]2[/SUP], Mouratidou E[SUP]2[/SUP], Tsiodras S[SUP]3[/SUP].
[h=3]Author information[/h] 1 National Public Health Organization, Athens, Greece. Electronic address: thlytras@gmail.com. 2 National Public Health Organization, Athens, Greece. 3 National Public Health Organization, Athens, Greece; 4th Department of Internal Medicine, Attikon University Hospital, University of Athens Medical School, Athens, Greece.

[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] Excess population mortality during winter is most often associated with influenza A(H3N2), though susceptibility differs by age. We examined differences between influenza types/subtypes in their association with severe laboratory-confirmed cases, overall and by age group, to determine which type is the most virulent.
[h=4]METHODS:[/h] We used nine seasons of comprehensive nationwide surveillance data from Greece (2010-2011 to 2018-2019) to examine the association, separately for influenza A(H1N1)pdm09, A(H3N2) and B, between the number of laboratory-confirmed severe cases (intensive care hospitalizations or deaths) per type/subtype and the overall type-specific circulation during the season (expressed as a cumulative incidence proxy). Quasi-Poisson models with identity link were used, and multiple imputation to handle missing influenza A subtype.
[h=4]RESULTS:[/h] For the same level of viral circulation and across all ages, influenza A(H1N1)pdm09 was associated with twice as many intensive care hospitalizations as A(H3N2) (Rate Ratio [RR] 1.89, 95%CI 1.38-2.74) and three times more than influenza B (RR 3.27, 95%CI 2.54-4.20). Similar associations were observed for laboratory-confirmed deaths. A(H1N1)pdm09 affected adults over 40 years at similar rates, whereas A(H3N2) affected the elderly at a much higher rate than younger persons (>=65 vs 40-64 years, RR for intensive care 5.42, 95%CI 3.45-8.65, and RR for death 6.19, 95%CI 4.05-9.38). Within the 40-64 years age group, A(H1N1)pdm09 was associated with an approximately five times higher rate of severe disease compared to both A(H3N2) and B.
[h=4]CONCLUSIONS:[/h] Influenza A(H1N1)pdm09 is associated with many more severe laboratory-confirmed cases, likely due to a more typical clinical presentation and younger patient age, leading to more testing. A(H3N2) affects older people more, with cases less often recognized and confirmed.
Copyright ? 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.


[h=4]KEYWORDS:[/h] infectious disease surveillance; influenza; influenza complications; influenza types/subtypes; intensive careunits; mortality; virulence

PMID: 31760112 DOI: 10.1016/j.cmi.2019.11.018
 
Back
Top Bottom